Advertisement
Invited Commentary| Volume 50, ISSUE 6, P744, December 2015

Open repair for chronic type B dissection

Open ArchivePublished:September 22, 2015DOI:https://doi.org/10.1016/j.ejvs.2015.08.011
      Endovascular intervention has revolutionised the treatment of complicated type B aortic dissection. In the acute setting, rupture, malperfusion, and refractory hypertension indicate complicated dissection requiring intervention, which is performed with thoracic endovascular aortic repair (TEVAR). The evidence for TEVAR is based on retrospective studies showing lower morbidity and mortality rates when compared with open surgical treatment for acute complicated dissections. However, most of acute type B dissections are uncomplicated and treated medically with strict control of blood pressure and heart rate. Approximately half of these patients will, with time, develop aneurysmal degeneration of the aorta.
      Chronic type B dissection aneurysms are often surgically challenging. The disease affects the descending thoracic aorta or thoraco-abdominal aorta, requiring extensive surgery if open repair is attempted, with significant risk of paraplegia and death. Although TEVAR is increasingly used in the treatment of chronic type B dissection, its applicability in this setting is debated owing to chronicity of the dissection flap and the existence of multiple re-entries affecting aortic remodelling.
      • Thrumurthy S.G.
      • Karthikesalingam A.
      • Patterson B.O.
      • Holt P.J.
      • Hinchliffe R.J.
      • Loftus I.M.
      • et al.
      A systematic review of mid-term outcomes of thoracic endovascular repair (TEVAR) of chronic type B aortic dissection.
      Recently, use of fenestrated and branched stent grafts for the treatment of chronic type B dissection aneurysms has been reported.
      • Kitagawa A.
      • Greenberg R.K.
      • Eagleton M.J.
      • Mastracci T.M.
      • Roselli E.E.
      Fenestrated and branched endovascular aortic repair for chronic type B aortic dissection with thoraco-abdominal aneurysms.
      • Oikonomou K.
      • Kopp R.
      • Katsargyris A.
      • Pfister K.
      • Verhoeven E.L.
      • Kasprzak P.
      Outcomes of fenestrated/branched endografting in post-dissection thoraco-abdominal aortic aneurysms.
      In the paper by Fujikawa et al.,
      • Fujikawa T.
      • Yamamoto S.
      • Sekine Y.
      • Oshima S.
      • Kasai R.
      • Mochida Y.
      • et al.
      Operative results and clinical features of chronic Stanford type B aortic dissection: the examination of 234 patients in six years.
      the results of open surgical correction of chronic type B dissection aneurysms is reported in a modern Japanese cohort. In this high volume aortic centre, 234 patients with descending thoracic or thoraco-abdominal reconstruction for chronic type B dissection were operated on over a period of 5.5 years. Peri-operative mortality was 3.9% after descending aortic repair (1.7% in elective cases), and 10.2% after thoraco-abdominal repair (8.2% in elective cases). There was no paraplegia after descending repair, while 4.7% of the thoraco-abdominal repairs resulted in paraplegia. No correlation was found between false lumen status and time elapsing from dissection to operation. Re-interventions after open repair were rare.
      The mortality and morbidity outcome of this case series is in line with other modern reports of open surgical repair for chronic dissection aneurysms.
      • Conway A.M.
      • Sadek M.
      • Lugo J.
      • Pillai J.B.
      • Pellet Y.
      • Panagopoulos G.
      • et al.
      Outcomes of open surgical repair for chronic type B aortic dissections.
      These results are to be compared with the outcome of TEVAR for chronic dissection: a systematic review reported a 30 day mortality rate of 3.2% and a paraplegia rate of 0.4%.
      • Thrumurthy S.G.
      • Karthikesalingam A.
      • Patterson B.O.
      • Holt P.J.
      • Hinchliffe R.J.
      • Loftus I.M.
      • et al.
      A systematic review of mid-term outcomes of thoracic endovascular repair (TEVAR) of chronic type B aortic dissection.
      However, TEVAR is associated with re-interventions in up to one- third of the patients over time.
      It can be questioned whether the results of the current report are transferrable to other centres. Most importantly, Fujukawa et al. report that an aortic dilatation of > 50 mm was regarded as an indication for treatment, which is in contrast to the 55 mm diameter threshold commonly used.
      • Fujikawa T.
      • Yamamoto S.
      • Sekine Y.
      • Oshima S.
      • Kasai R.
      • Mochida Y.
      • et al.
      Operative results and clinical features of chronic Stanford type B aortic dissection: the examination of 234 patients in six years.
      • Nienaber C.A.
      • Divchev D.
      • Palisch H.
      • Clough R.E.
      • Richartz B.
      Early and late management of type B aortic dissection.
      In addition, 16% of the patients treated in this series were operated on despite complete false lumen thrombosis, and the authors state that no patients were turned down for surgery. This is surprising when the treatment is associated with a peri-operative mortality risk of up to 10%.
      The current paper adds to the literature regarding modern outcomes of open surgical repair of chronic dissection aneurysms. It also underlines the complexity of this disease, and the variations in practice and management across centres. Chronic dissection aneurysms continue to require challenging surgical treatment, whether performed with open, endovascular, or hybrid repair.

      References

        • Thrumurthy S.G.
        • Karthikesalingam A.
        • Patterson B.O.
        • Holt P.J.
        • Hinchliffe R.J.
        • Loftus I.M.
        • et al.
        A systematic review of mid-term outcomes of thoracic endovascular repair (TEVAR) of chronic type B aortic dissection.
        Eur J Vasc Endovasc Surg. 2011; 42: 632-647
        • Kitagawa A.
        • Greenberg R.K.
        • Eagleton M.J.
        • Mastracci T.M.
        • Roselli E.E.
        Fenestrated and branched endovascular aortic repair for chronic type B aortic dissection with thoraco-abdominal aneurysms.
        J Vasc Surg. 2013; 58: 625-634
        • Oikonomou K.
        • Kopp R.
        • Katsargyris A.
        • Pfister K.
        • Verhoeven E.L.
        • Kasprzak P.
        Outcomes of fenestrated/branched endografting in post-dissection thoraco-abdominal aortic aneurysms.
        Eur J Vasc Endovasc Surg. 2014; 48: 641-648
        • Fujikawa T.
        • Yamamoto S.
        • Sekine Y.
        • Oshima S.
        • Kasai R.
        • Mochida Y.
        • et al.
        Operative results and clinical features of chronic Stanford type B aortic dissection: the examination of 234 patients in six years.
        Eur J Vasc Endovasc Surg. 2015;
        • Conway A.M.
        • Sadek M.
        • Lugo J.
        • Pillai J.B.
        • Pellet Y.
        • Panagopoulos G.
        • et al.
        Outcomes of open surgical repair for chronic type B aortic dissections.
        J Vasc Surg. 2014; 59: 1217-1223
        • Nienaber C.A.
        • Divchev D.
        • Palisch H.
        • Clough R.E.
        • Richartz B.
        Early and late management of type B aortic dissection.
        Heart. 2014; 100: 1491-1497

      Linked Article

      • Operative Results and Clinical Features of Chronic Stanford Type B Aortic Dissection: Examination of 234 Patients Over 6 Years
        European Journal of Vascular and Endovascular SurgeryVol. 50Issue 6
        • Preview
          Recently, the indications for thoracic endovascular aortic repair (TEVAR) have been expanding, and the applicability of TEVAR for acute type B aortic dissection (TBAD) is proposed with regard to the high mortality of open surgery for chronic TBAD. TEVAR in the acute phase may lead to remodeling of the false lumen (FL), but it is controversial whether it completely resolves the aortic expansion in the chronic phase. In this study, operative results and the relationship between FL status and the time before surgical intervention were retrospectively analyzed.
        • Full-Text
        • PDF
        Open Archive

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.